HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gil Navon Selected Research

Neoplasms (Cancer)

11/2022Breast cancer imaging with glucosamine CEST (chemical exchange saturation transfer) MRI: first human experience.
7/2022Phosphate buffer-catalyzed kinetics of mutarotation of glucosamine investigated by NMR spectroscopy.
2/2022What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report.
1/2021Molecular imaging of cancer by glucosamine chemical exchange saturation transfer MRI: A preclinical study.
10/2019Molecular imaging of tumors by chemical exchange saturation transfer MRI of glucose analogs.
1/2019Quantification of hydroxyl exchange of D-Glucose at physiological conditions for optimization of glucoCEST MRI at 3, 7 and 9.4 Tesla.
10/20183-O-Methyl-D-glucose mutarotation and proton exchange rates assessed by 13C, 1H NMR and by chemical exchange saturation transfer and spin lock measurements.
1/2018CEST MRI of 3-O-methyl-D-glucose on different breast cancer models.
1/2016Glucosamine and N-acetyl glucosamine as new CEST MRI agents for molecular imaging of tumors.
11/2014Functional molecular imaging of tumors by chemical exchange saturation transfer MRI of 3-O-Methyl-D-glucose.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gil Navon Research Topics

Disease

11Neoplasms (Cancer)
11/2022 - 10/2013
3Breast Neoplasms (Breast Cancer)
12/2023 - 01/2018
2Neoplasm Metastasis (Metastasis)
11/2014 - 10/2013
1Brain Diseases (Brain Disorder)
12/2023
1Inflammation (Inflammations)
01/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2023
1Cicatrix (Scar)
01/2017
1Fibrosis (Cirrhosis)
01/2017
1Osteoarthritis
09/2010
1Ischemia
12/2002
1Hypothyroidism
12/2002

Drug/Important Bio-Agent (IBA)

6Glucose (Dextrose)FDA LinkGeneric
02/2022 - 12/2002
4Glucosamine (Dona)IBA
12/2023 - 01/2016
33-O-Methylglucose (3 O Methylglucose)IBA
10/2018 - 11/2014
2CollagenIBA
01/2023 - 01/2017
2Contrast MediaIBA
11/2022 - 07/2022
1Biomarkers (Surrogate Marker)IBA
12/2023
1C.I. direct red 80IBA
01/2023
1Eosine Yellowish-(YS) (Eosin)IBA
01/2023
1Hematoxylin (Haematoxylon)IBA
01/2023
1Hydroxyl RadicalIBA
11/2022
1Protons (Proton)IBA
11/2022
1AminesIBA
11/2022
1AmidesIBA
11/2022
1Teriparatide (Parathar)FDA Link
01/2017
1Parathyroid Hormone (Parathormone)IBA
01/2017
1AcetylglucosamineIBA
01/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2013
1Deoxyglucose (2 Deoxy D glucose)IBA
10/2013
1IsotopesIBA
10/2013
1Proteoglycans (Proteoglycan)IBA
09/2010
1Lactic Acid (Lactate)FDA LinkGeneric
12/2002
1Thyroxine (Levothyroxine)FDA LinkGeneric
12/2002
1GlycogenIBA
12/2002

Therapy/Procedure

2Therapeutics
10/2019 - 10/2013